Literature DB >> 19799972

Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation.

Yueshan Hu1, Hesham Fahmy, Jordan K Zjawiony, Gareth E Davies.   

Abstract

It has been reported that the botanical alkaloids, berberine and evodiamine inhibit mouse preadipocyte 3T3-L1 differentiation. The aim of this study was to investigate the effect and transcriptional impact of berberine and evodiamine individually and in combination on human white preadipocyte (HWP) differentiation. We have shown that treatment with 8 microM berberine or 4 microM evodiamine resulted in a major inhibition of HWP differentiation accompanied by up-regulation of both GATA binding protein 2 and 3 (GATA-2 and GATA-3) mRNA and protein expression, suggesting that both compounds may have excellent potential as agents to prevent obesity. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799972     DOI: 10.1016/j.fitote.2009.09.012

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  11 in total

1.  Protective effects of berberine on high fat-induced kidney damage by increasing serum adiponectin and promoting insulin sensitivity.

Authors:  Ueyue Wu; Ying Cha; Xinmei Huang; Jun Liu; Zaoping Chen; Fang Wang; Jiong Xu; Li Sheng; Heyuan Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components.

Authors:  Jyh-Fei Liao; Wen-Fei Chiou; Yuh-Chiang Shen; Guei-Jane Wang; Chieh-Fu Chen
Journal:  Chin Med       Date:  2011-02-14       Impact factor: 5.455

3.  Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients.

Authors:  Jing Yang; Jinhua Yin; Hongfei Gao; Linxin Xu; Yan Wang; Lu Xu; Ming Li
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

4.  Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.

Authors:  Xin Zhou; Fengying Ren; Hong Wei; Liyun Liu; Tao Shen; Shijun Xu; Jiangping Wei; Jiayue Ren; Hengfan Ni
Journal:  Lipids Health Dis       Date:  2017-12-11       Impact factor: 3.876

Review 5.  Pharmacological actions of multi-target-directed evodiamine.

Authors:  Hui Yu; Hongwei Jin; Wuzhuang Gong; Zhanli Wang; Huaping Liang
Journal:  Molecules       Date:  2013-01-31       Impact factor: 4.411

6.  Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages: role of liver X receptor α.

Authors:  Jin-Feng Zhao; Li-Chieh Ching; Yu Ru Kou; Shing-Jong Lin; Jeng Wei; Song-Kun Shyue; Tzong-Shyuan Lee
Journal:  Mediators Inflamm       Date:  2013-06-26       Impact factor: 4.711

7.  Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.

Authors:  Bhimanna Kuppast; Katerina Spyridaki; Christophina Lynch; Yueshan Hu; George Liapakis; Gareth E Davies; Hesham Fahmy
Journal:  Med Chem       Date:  2014       Impact factor: 2.745

8.  Metformin and berberine prevent olanzapine-induced weight gain in rats.

Authors:  Yueshan Hu; Alan J Young; Erik A Ehli; Dustin Nowotny; Paige S Davies; Elizabeth A Droke; Timothy J Soundy; Gareth E Davies
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

9.  A promising antitumor activity of evodiamine incorporated in hydroxypropyl-β-cyclodextrin: pro-apoptotic activity in human hepatoma HepG2 cells.

Authors:  Chao Qiu; Li-Na Gao; Kuo Yan; Yuan-Lu Cui; Ye Zhang
Journal:  Chem Cent J       Date:  2016-07-25       Impact factor: 4.215

Review 10.  miRNAs and Novel Food Compounds Related to the Browning Process.

Authors:  Silvia Lorente-Cebrián; Katya Herrera; Fermín I Milagro; Juana Sánchez; Ana Laura de la Garza; Heriberto Castro
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.